Milan, Italy

Pierluigi Farina

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Recordati Industria Chimica E Farmaceutica S.p.a.. Active years: 2021.


% Patents Active = 100.0


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pierluigi Farina: Innovator in Pharmaceutical Formulations

Introduction

Pierluigi Farina is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for parenteral administration. His work is characterized by a focus on innovative solutions that enhance the efficacy and safety of pharmaceutical products.

Latest Patents

Farina holds a patent for a pharmaceutical parenteral formulation containing carglumic acid. This invention relates to a formulation suitable for parenteral administration that includes carglumic acid and a buffering agent with a pK from 5.5 to 9.0 at 25°C. The formulation may also contain at least one bulking agent, such as mannitol. The invention encompasses a method for manufacturing a lyophilized sterile formulation by freeze-drying a water solution containing carglumic acid and the buffering agent.

Career Highlights

Farina is associated with Recordati Industria Chimica e Farmaceutica S.p.A., where he has been instrumental in advancing pharmaceutical research and development. His expertise in formulation science has contributed to the company's reputation for innovation in the pharmaceutical industry.

Collaborations

Farina has collaborated with notable colleagues, including Fabio Berlati and Sergio Menegon. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical development.

Conclusion

Pierluigi Farina's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the field. His patent for carglumic acid formulations highlights the importance of research in developing effective medical solutions. Farina's work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…